Japan approves GSK’s rotavirus vaccine
The Japanese regulator has approved a rotavirus vaccine developed by GlaxoSmithKline Plc to prevent gastroenteritis caused by rotavirus in infants. The vaccine contains a live, attenuated form of the human rotavirus, RIX4414 strain.